NOUVEAUX SELS PENTADÉCAPEPTIDES STABLES, PROCÉDÉ DE PRÉPARATION ASSOCIÉ, LEUR UTILISATION DANS LA FABRICATION DE PRÉPARATIONS PHARMACEUTIQUES ET LEUR UTILISATION EN THÉRAPIE
The present invention discloses new stable pentadecapeptide salts of formula (I): (I) SEQ&emsp；ID&emsp；NO&emsp；1 Gly&emsp；Glu&emsp；Pro&emsp；Pro&emsp；Pro&emsp；Gly&emsp；Lys&emsp；Pro&emsp；Ala&emsp；Asp&emsp；Asp&emsp；Ala 1&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；5&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；10&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp； Gly&emsp；Leu&emsp；Val&emsp；· n&emsp；BAA &emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；&emsp；15 wherein n means 1, 2 or 3, and BAA means basic amino acid, a process for the preparation thereof, a process for the use thereof for the manufacture of pharmaceutical formulations in liquid and solid form and a use thereof for prevention, protection in treatment of diseases and disease conditions and for the preparation of formulations for use as food supplements.
